Furthermore, NK cells of HC and CLL were equally activated after co-culture with rituximab treated Daudi cells, leading to a similar proportion of IFNγ producing NK cells (Fig. 5I+J). Here, IFNG is linked to B-cell chronic lymphocytic leukemia.